Alembic Pharmaceuticals Ltd.
| BSE: 533573 | Sector: Health care |
| NSE: APLLTD | ISIN Code: INE901L01018 |
| BSE 12:31 | 06 Feb | 530.30 |
-4.95 (-0.92%) |
OPEN
535.25 |
HIGH
535.45 |
LOW
529.05 |
| NSE 12:19 | 06 Feb | 530.10 |
-5.05 (-0.94%) |
OPEN
535.15 |
HIGH
536.00 |
LOW
529.10 |
| OPEN | 535.25 |
| PREVIOUS CLOSE | 535.25 |
| VOLUME | 2290 |
| 52-Week high | 792.30 |
| 52-Week low | 525.30 |
| P/E | 22.29 |
| Mkt Cap.(Rs cr) | 10,423 |
| Buy Price | 530.05 |
| Buy Qty | 8.00 |
| Sell Price | 530.70 |
| Sell Qty | 1.00 |
Alembic Pharmaceuticals Ltd. (APLLTD) - Announcements
-
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Appointment of Company Secretary and Compliance Officer
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December 2022
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
01/02/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
28/01/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/01/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19/01/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
19/01/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
06/01/2023 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Closure of Trading Window
29/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
26/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
26/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd USFDA Inspection At Alembic Pharmaceuticals Solid Oral Formulation Facility (F-4) At Jarod
19/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
12/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) For Its Oncology Inje
09/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
09/12/2022 | bse |
Downlaod PDF -
Alembic Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
02/12/2022 | bse |
Downlaod PDF
Quick Links for Alembic Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
